Updates This is the second version (first update) of the living systematic review, replacing
the previous version (available as a data supplement). When citing this paper please …

Background Populations such as healthcare workers (HCW) that are unable to practice
physical distancing are at high risk of acquiring Coronavirus disease-2019 (COVID-19). In …

Clinical question What is the role of drugs in preventing covid-19? Why does this matter?
There is widespread interest in whether drug interventions can be used for the prevention of …

Background Hydroxychloroquine (HCQ) is an anti-malarial and immunomodulatory drug
considered a potential candidate for drug repurposing in COVID-19 due to their in vitro …

Summary Since coronavirus disease 2019 (COVID‐19) emerged in Wuhan, China in
December 2019 and spread around the world, over 1100 clinical studies have been …

Abstract Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …

Background As COVID-19 cases continue to rise globally, evidence from large randomized
controlled trials is still lacking. Currently, numerous trials testing potential treatment and …

Background While the landscape of vaccine and treatment candidates against the novel
coronavirus disease 2019 (COVID-19) has been reviewed systematically, prophylactic …

Objective The pandemic coronavirus disease‐19 (COVID‐19) has pushed the global
healthcare system to a crisis and amounted to a huge economic burden. Different drugs for …

Background We examined whether existing licensed pharmacotherapies could reduce the
spread of coronavirus disease 2019 (COVID-19). Methods An open-label parallel …